CUSIP: 192003101
Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,280,595
-
Share change
-
-585,477
-
Total reported value
-
$4,500,115
-
Put/Call ratio
-
0%
-
Price per share
-
$0.40
-
Number of holders
-
24
-
Value change
-
-$658,896
-
Number of buys
-
10
-
Number of sells
-
11
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2024
-
Previous quarter:
Q3 2023
Recent filing periods for CUSIP 192003101:
Institutional Holders of CODEX DNA INC - COM (TBIO) as of Q4 2023
As of 31 Dec 2023,
CODEX DNA INC - COM (TBIO) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,280,595 shares.
The largest 10 holders included
Northpond Ventures, LLC, VANGUARD GROUP INC, Penbrook Management LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Vontobel Holding Ltd., CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, and BlackRock Inc..
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.